Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-10

Clinical Trial Update: Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial compares pulpotomy using Neoputty Mineral Trioxide Aggregate with pulpectomy using Endoflas in primary molars with irreversible pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Endoflas (Endoflas root canal sealer)
  • Neoputty Mineral Trioxide Aggregate (Mineral Trioxide Aggregate)

Snippet

Sponsor: Cairo University | Conditions: Pulpitis - Irreversible | NA | Status: NOT_YET_RECRUITING